A case report of pelviscopic resection of invasive hydatidiform mole
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hyun Joo | - |
dc.contributor.author | Kim, Yun Sook | - |
dc.date.accessioned | 2021-08-11T09:24:03Z | - |
dc.date.available | 2021-08-11T09:24:03Z | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.issn | 1536-5964 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4173 | - |
dc.description.abstract | Rationale: Invasive moles occur in the fertile period, with about 95% occurring after previous mole removal and the remaining 5% occurring after several other pregnancies. Patient concerns: A 27-year-old patient developed a rare invasive mole two months after a missed abortion. Diagnoses: A transvaginal ultrasound scan revealed a 3.6 x 2.9 x 2.4cm sized lesion with cystic vascular areas within it, within the myometrium of the right fundal posterior region of the uterus. There was no metastasis to other organs. Interventions: After administration of methotrexate, the level of beta-human chorionic gonadotropin (beta-hCG) was elevated and liver enzymes were also markedly elevated. She wanted to retain fertility for future pregnancies. After laparoscopic removal of the myometrial invasive mole, the incision site was sutured with a 3-0 V-Loc (TM). Outcomes: One year later, a natural pregnancy occurred and a cesarean section was performed at 36 weeks. Lessons: This is the first reported case of its type. Our case demonstrated that pelviscopic removal of an invasive mole is possible if there are no other metastases, and that future pregnancy and childbirth are still feasible in women of reproductive age. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | A case report of pelviscopic resection of invasive hydatidiform mole | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/MD.0000000000017565 | - |
dc.identifier.scopusid | 2-s2.0-85072949014 | - |
dc.identifier.wosid | 000491349800066 | - |
dc.identifier.bibliographicCitation | Medicine, v.98, no.41 | - |
dc.citation.title | Medicine | - |
dc.citation.volume | 98 | - |
dc.citation.number | 41 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordAuthor | beta-human chorionic gonadotropin | - |
dc.subject.keywordAuthor | invasive mole | - |
dc.subject.keywordAuthor | pelviscopy | - |
dc.subject.keywordAuthor | transvaginal ultrasound | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.